Authors:
Brandt-Mainz, K
von Mallek, D
Pottgen, C
Eising, EG
Bockisch, A
Stuschke, M
Sack, H
Citation: K. Brandt-mainz et al., Parametric oesophageal multiple swallow scintigraphy for validation of dysphageal symptoms during external beam irradiation of mediastinal tumours, EUR J NUCL, 28(3), 2001, pp. 313-319
Authors:
Muller, WU
Bauch, T
Stuben, G
Sack, H
Streffer, C
Citation: Wu. Muller et al., Radiation sensitivity of lymphocytes from healthy individuals and cancer patients as measured by the comet assay, RADIAT ENV, 40(1), 2001, pp. 83-89
Citation: H. Sack, Risk factors for local recurrence and distant metastases after breast conserving therapy for ductal carcinoma in situ, STRAH ONKOL, 177(10), 2001, pp. 557-557
Authors:
Fischer, M
Stuben, G
Klahold, M
Stuschke, M
Budach, V
Sack, H
Jahnke, K
Citation: M. Fischer et al., Accelerated hyperfractionated radiotherapy with concurrent chemotherapy inlocally advanced nasopharyngeal carcinoma: a phase II study, J CANC RES, 127(8), 2001, pp. 507-511
Authors:
Stuschke, M
Stahl, M
Wilke, H
Walz, M
Oldenburg, A
Stuben, G
Seeber, S
Sack, H
Citation: M. Stuschke et al., Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the upper-thoracic and midthoracic esophagus, AM J CL ONC, 23(3), 2000, pp. 233-238
Citation: H. Sack, Effectiveness of surgical salvage therapy for patients with locally advanced uncontrolled anal carcinoma after sphincter-conserving treatment, STRAH ONKOL, 176(2), 2000, pp. 97-97
Authors:
Stuschke, M
Eberhardt, W
Pottgen, C
Stamatis, G
Wilke, H
Stuben, G
Stoblen, F
Wilhelm, HH
Menker, H
Teschler, H
Muller, RD
Budach, V
Seeber, S
Sack, H
Citation: M. Stuschke et al., Prophylactic cranial irradiation in locally advanced non-small-cell lung cancer after multimodality treatment: Long-term follow-up and investigationsof late neuropsychologic effects, J CL ONCOL, 17(9), 1999, pp. 2700-2709
Authors:
Zolzer, F
Stuben, G
Knuhmann, K
Streffer, C
Sack, H
Citation: F. Zolzer et al., Quiescent S-phase cells as indicators of extreme physiological conditions in human tumor xenografts, INT J RAD O, 45(4), 1999, pp. 1019-1024
Authors:
Stuben, G
Thews, O
Pottgen, C
Stuschke, M
Sack, H
Citation: G. Stuben et al., Tumour oxygenation during fractionated radiotherapy - Comparison with size-matched controls, ACTA ONCOL, 38(2), 1999, pp. 209-213
Citation: H. Sack et P. Meusers, Prospects for the management of non-Hodgkin's lymphomas with monoclonal antibodies in immunoconjugates, STRAH ONKOL, 175(4), 1999, pp. 192-193
Authors:
Sauerwein, W
Moss, R
Rassow, J
Stecher-Rasmussen, F
Hideghety, K
Wolbers, JG
Sack, H
Citation: W. Sauerwein et al., Organisation and management of the first clinical trial of BNCT in Europe (EORTC protocol 11961), STRAH ONKOL, 175, 1999, pp. 108-111
Authors:
Stuschke, M
Stahl, M
Wilke, H
Walz, MK
Oldenburg, AR
Stuben, G
Jahnke, K
Seeber, S
Sack, H
Citation: M. Stuschke et al., Induction chemotherapy followed by concurrent chemotherapy and high-dose radiotherapy for locally advanced squamous cell carcinoma of the cervical oesophagus, ONCOL-BASEL, 57(2), 1999, pp. 99-105
Authors:
Eberhardt, W
Stamatis, G
Stuschke, M
Wilke, H
Muller, MR
Kolks, S
Flasshove, M
Schutte, J
Stahl, M
Schlenger, L
Budach, V
Greschuchna, D
Stuben, G
Teschler, H
Sack, H
Seeber, S
Citation: W. Eberhardt et al., Prognostically orientated multimodality treatment including surgery for selected patients of small-cell lung cancer patients stages IB to IIIB: long-term results of a phase II trial, BR J CANC, 81(7), 1999, pp. 1206-1212